Package 70518-2458-2

{"route": ["ORAL"], "spl_id": "4a2942e2-f01f-a422-e063-6394a90a2984", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["080853c0-fcab-4645-9ddc-4946e895ac5f"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2458-0)", "package_ndc": "70518-2458-0", "marketing_start_date": "20191129"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2458-2)", "package_ndc": "70518-2458-2", "marketing_start_date": "20200706"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2458-6)", "package_ndc": "70518-2458-6", "marketing_start_date": "20240812"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2458-7)", "package_ndc": "70518-2458-7", "marketing_start_date": "20250327"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "70518-2458_4a2942e2-f01f-a422-e063-6394a90a2984", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-2458", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20191129", "listing_expiration_date": "20271231"}